# Field-Deployable, Low-Cost Point-of-Need Approaches and Technologies to Lower the Barriers to Substance Use Disorders (SUD) Diagnosis and Treatment (R43/R44 Clinical Trial Optional)

Source: https://welltoldgrants.com/grants/rfa-da-24-018-field-deployable-low-cost-point-of-need-approaches/  
Official notice: https://www.grants.gov/search-results-detail/348339

> National Institutes of Health offered grants of up to $295,924 to small businesses. Applications closed on November 10, 2023.

| Field | Value |
|---|---|
| Opportunity number | RFA-DA-24-018 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | November 10, 2023 |
| Award ceiling | $295,924 |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.279 |

## Who can apply

- Small businesses

Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. See full Notice of Funding Opportunity for additional details on eligibility.

## What the grant funds

The FOA intends to spur the development of cost-effective technologies that may reduce or even eliminate disparities in SUD treatment. Disparities due to geographical access or rural/urban divide, due to treatment cost, or due to stigma will be specifically targeted. The intention is to bring to the treatment to the patient, not the patient to the treatment.

## Questions people ask

### Is RFA-DA-24-018 still open?

No. It closed on November 10, 2023.

### Who can apply for Field-Deployable, Low-Cost Point-of-Need Approaches and Technologies to Lower the Barriers to Substance Use Disorders (SUD) Diagnosis and Treatment (R43/R44 Clinical Trial Optional)?

National Institutes of Health accepted applications from small businesses. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Field-Deployable, Low-Cost Point-of-Need Approaches and Technologies to Lower the Barriers to Substance Use Disorders (SUD) Diagnosis and Treatment (R43/R44 Clinical Trial Optional)?

Closed November 10, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $295,924 each.

### Who has been funded under RFA-DA-24-018?

NIH RePORTER lists 5 projects funded under RFA-DA-24-018 in fiscal 2024 to 2026, at 5 institutions. The most were at Boulder Care, Inc., Sano Healthcare Consultants, LLC, Labsys, LLC.

### Who has won Drug Use and Addiction Research Programs grants before?

The largest recipients over five fiscal years were Yale Univ, The Johns Hopkins University, University of California, San Diego. The program made 5,071 awards worth $7.3 billion in that time.